ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

BACKGROUND: The treatment of advanced gastric cancer with curative intent is essentially surgical and chemoradiotherapy is indicated as neo or adjuvant to control the disease and prolong survival. AIM: To assess the survival of patients undergoing subtotal or total gastrectomy with D2 lymphadenectom...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arq Bras Cir Dig
Asıl Yazarlar: ANDREOLLO, Nelson Adami, DRIZLIONOKS, Eric, TERCIOTI-JUNIOR, Valdir, COELHO-NETO, João de Souza, FERRER, José Antonio Possato, CARVALHEIRA, José Barreto Campello, LOPES, Luiz Roberto
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Colégio Brasileiro de Cirurgia Digestiva 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6918727/
https://ncbi.nlm.nih.gov/pubmed/31859917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0102-672020190001e1464
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller